
|Articles|May 21, 2007
Latebreakers: Transdermal option given OK for Parkinson's disease
A unique delivery for a new dopamine agonist has been approved to treat symptoms of early Parkinson's disease (PD).
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
TrumpRx Officially Launches, Introduces Drug Prices
2
President Trump Signs Sweeping, Unprecedented Federal PBM Reform
3
As Immunization Schedules Change, Vaccine Confidence Among Patients Falters
4
Q&A: PBMs, Community Pharmacy’s Next Move Following PBM Reform Signing
5























